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We thank Gabrielli et al for their interest in and valuable comments about our article in Circulation 1 . We agree that not all antibodies used in our trial necessarily indicate persistent infections. However, this was not our intention. We measured IgG and/or IgA antibodies to 8 pathogens (Chlamydia pneumoniae, Helicobacter pylori, Haemophilus influenzae, Mycoplasma pneumoniae, cytomegalovirus, Epstein-Barr virus, and herpes simplex virus type 1 and 2) to evaluate the total pathogen burden of each individual. [1] [2] According to the hypotheses of Zhu and Epstein, [3] [4] it is unlikely that one single pathogen is involved in the pathogenesis of atherosclerosis. This is supported by our findings, showing a significant relation between the number of infectious pathogens to which an individual has been exposed and the extent of atherosclerosis. 1 Gabrielli et al point out in their letter that autoreactive T cells may represent a potential reservoir of pathogenic effectors. Indeed, infection by multiple pathogens, contributing to pathogen burden, may trigger an immune response with pathogentargeted antibodies and/or T cells, and these mechanisms may be involved in the pathogenesis and progression of atherosclerosis. 5 Furthermore, we agree that these immune-mediated mechanisms may occur after the pathogen has been removed. This theory confirms the results of our study-namely, that infectious burden does play a role in the pathogenesis of atherosclerosis and that various immune mechanisms are involved in these processes.
